Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/AVCT stock hub

AIM/AVCT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/AVCTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

374M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/AVCT

In the news

Latest news · AIM/AVCT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-167.9

P25 -54.2P50 2.1P75 13.7

ROIC-38.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/AVCT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

180

Groups with data

Currency

GBP

Showing 180 of 180 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	151
Employees Change	-3%
Employees Change Percent	-1.95
Enterprise value	GBX 381.7M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BYYW9G87
Last refreshed	2026-05-10
Market cap	GBX 374M
Price	GBX 82.5
Price currency	GBX
Rev Per Employee	748.34x
Sector	Healthcare
Sic	8731
Symbol	aim/AVCT
Website	https://avacta.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-16.74%
EV Earnings	-6.1x
EV/FCF	-15.35x
FCF yield	-6.65%
P/B ratio	2,596.91x
P/S ratio	3,309.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	GBX 113,000
Gross Profit Growth	0%
Gross Profit Growth Q	0%
Gross Profit Growth3 Y	-77.55%
Gross Profit Growth5 Y	-54.03%
Net Income	GBX -62.6M
Net Income Growth Years	0%
Pretax Margin	-35,467.26%
Profit Per Employee	GBX -414,596
ROA	-32.63
Roa5y	-25.62
ROCE	-2,311
ROE	-167.9
Roe5y	-117.2
ROIC	-38.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-2.43%
Cagr15y	-2.27%
Cagr1y	146.42%
Cagr3y	-10.74%
Cagr5y	-20.63%
EPS Growth Quarters	3
EPS Growth Years	0
Revenue Growth	-96.04x
Revenue Growth Years	0x
Revenue Growth3 Y	-82.08x
Revenue Growth5 Y	-57.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0
Assets	GBX 29.2M
Cash	GBX 12.6M
Current Assets	GBX 22M
Current Liabilities	GBX 27.9M
Debt	GBX 20.4M
Debt Equity	GBX 142
Debt FCF	GBX -0.82
Equity	GBX 144,000
Interest Coverage	-3.68
Liabilities	GBX 29.1M
Long Term Assets	GBX 7.2M
Long Term Liabilities	GBX 1.2M
Net Cash	GBX -7.8M
Net Cash By Market Cap	GBX -2.07
Net Debt Equity	GBX 53.88
Tangible Book Value	GBX -1.7M
Tangible Book Value Per Share	GBX -0
WACC	5.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.79
Net Working Capital	GBX 864,000
Quick ratio	0.65
Working Capital	GBX -5.9M
Working Capital Turnover	GBX 0.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-21.78%
1Y total return	146.27%
200-day SMA	63.67
3Y total return	-28.88%
50-day SMA	70.24
50-day SMA vs 200-day SMA	50over200
5Y total return	-68.5%
All Time High	2,295
All Time High Change	-96.41%
All Time High Date	2008-03-04
All Time Low	11
All Time Low Change	650%
All Time Low Date	2009-07-27
ATR	5.21
Beta	-0.1
Beta1y	0.79
Beta2y	0.71
Ch YTD	42.24
High	85
High52	85
High52 Date	2026-05-08
High52ch	-2.94%
Low	78
Low52	26
Low52 Date	2025-05-27
Low52ch	217.31%
Ma50ch	17.45%
Price vs 200-day SMA	29.58%
RSI	62.9
RSI Monthly	56.07
RSI Weekly	64.85
Sharpe ratio	1.57x
Sortino ratio	2.84
Total Return	-29.48%
Tr YTD	42.24
Tr15y	-29.16%
Tr1m	24.62%
Tr1w	10%
Tr3m	36.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -30.9M
Operating margin	-27,384.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	425,607,287%
Net Borrowing	-3,501,000
Shares Insiders	0.02%
Shares Institutions	75.19%
Shares Out	453,278,082
Shares Yo Y	29.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -27.3M
Average Volume	2,506,356.65x
Bv Per Share	0
CAPEX	GBX -79,000
Ch10y	-21.8
Ch15y	-29.18
Ch1m	24.62
Ch1w	10
Ch1y	146.3
Ch3m	36.36
Ch3y	-28.88
Ch5y	-68.51
Ch6m	17.02
Change	1.85%
Change From Open	0.61
Close	81
Days Gap	1.23
Depreciation Amortization	1,544,000
Dollar Volume	436,072,312.5
Earnings Date	2026-05-12
EBIT	GBX -30.9M
EBITDA	GBX -29.4M
EPS	GBX -0.17
F Score	1
FCF	GBX -24.9M
FCF EV Yield	-6.51x
FCF Per Share	GBX -0.05
Financing CF	-2,331,000
Fiscal Year End	December
Founded	2,003
Income Tax	GBX 486,000
Investing CF	8,137,000
Is Primary Listing	1
Last Earnings Date	2026-01-05
Last Report Date	2025-06-30
Last Split Date	2016-01-26
Last Split Type	Reverse
Ma150	67.51
Ma150ch	22.2%
Ma20	75
Ma20ch	10%
Net CF	-18,745,000
Next Earnings Date	2026-05-12
Open	82
Position In Range	64.29
Ppne	2,100,000
Price Date	2026-05-08
Relative Volume	2.11x
Revenue	113,000x
SBC By Revenue	2,146.9x
Share Based Comp	2,426,000
Tax By Revenue	430.09x
Tr6m	17.02%
Volume	5,285,725
Z Score	-7.57

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/AVCT pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/AVCT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/AVCT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+75.2%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+29.5%

Negative means the company is buying back shares.

Technical

AIM/AVCT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

62.9

Neutral momentum band

Price vs 200-day MA

+29.6%

50/200-day relationship not available

Beta (5Y)

-0.10

Less volatile than the market

Sharpe ratio

1.57

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/AVCT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/AVCT stock rating?

aim/AVCT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/AVCT analysis?

The full report lives at /stocks/aim/AVCT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/AVCT?

The latest report frames aim/AVCT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/AVCT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.